TrialBMC cancer2021

A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer.

Dongling Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.